List view / Grid view
21 February 2014 | By Merck
MSD has announced full study findings from a pan-European observational study that showed the majority of moderate-to-severe ulcerative colitis patients who were treated with conventional therapies failed to achieve well-controlled disease status...
21 February 2014 | By GlaxoSmithKline
GlaxoSmithKline plc announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a positive opinion recommending marketing authorisation for umeclidinium under the proposed brand name Incruse®...
20 February 2014 | By Merck
Merck announced that the Biologics License Application for V503...
20 February 2014 | By GlaxoSmithKline
GlaxoSmithKline plc and Theravance, Inc. announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a positive opinion recommending marketing authorisation for umeclidinium/vilanterol under the proposed brand name Anoro®...
19 February 2014 | By Novartis
Novartis announced that the pivotal trial of the investigational oral compound LDE225 in advanced basal cell carcinoma met its primary endpoint of demonstrating an objective response rate among patients within six months of treatment...
19 February 2014 | By The European Medicines Agency
The European Medicines Agency and the United States Food and Drug AdministrationExternal link icon have set up a new 'cluster' on pharmacovigilance topics...
19 February 2014 | By Paul Wituschek, Vice President of Sales, Development and Clinical Services, Catalent
Paul Wituschek, Vice President of Sales, Development and Clinical Services, Catalent answers the question: "Other than oncology, for which disease areas do you see Antibody Drug Conjugates (ADC) being used extensively in the future?"
19 February 2014 | By Allen L. Burgenson, Manager - Regulatory Affairs, Lonza Walkersville, Inc
Allen L. Burgenson, Manager - Regulatory Affairs, Lonza Walkersville, Inc answers the question “From a vendor perspective, do you conclude that Big Pharma is still actively engaging in outsourcing of the activities that you have expertise in?”
19 February 2014 | By Edward Dell, International Marketing Director, BMG Labtech
Edward Dell, International Marketing Director, BMG Labtech answers the question "Although photomultiplier based plate-readers offer increased sensitivity compared to CCD imaging based plate-readers, they take longer to collect data from a microtitre plate. How do your customers balance throughput versus sensitivity when considering which plate-reader to purchase?"
18 February 2014 | By Avillion LLP
Avillion LLP announced it has appointed Dr Allison Jeynes-Ellis MB, ChB, FFPM as Chief Executive Officer...
17 February 2014 | By Novartis
Novartis announced that it is broadening its cancer immunotherapy research program with the acquisition of CoStim Pharmaceuticals Inc...
17 February 2014 | By The European Medicines Agency
The European Medicines Agency is pleased to welcome Dina Tsiambaou as the new Head of IT Development Department in the Information Technology Division...
17 February 2014 | By Merck
MSD Animal Health announced that following a positive opinion from the Committee for Medicinal Products for Veterinary Use, the European Commission has granted marketing authorization for the veterinary medicinal product BRAVECTO™...
17 February 2014 | By Boehringer Ingelheim
Boehringer Ingelheim Fremont Inc. received the East Bay Innovation Award in recognition for its contribution to the East Bay's culture of innovation...
17 February 2014 | By Biogen Idec
Stelios Papadopoulos to become Chairman of the Board...
